c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells
- PMID: 2464742
- PMCID: PMC365424
- DOI: 10.1128/mcb.8.9.3683-3695.1988
c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells
Abstract
Friend murine erythroleukemia (F-MEL) cells were transfected with a plasmid bearing tandemly arranged mouse c-myc antisense and dihydrofolate reductase transcription units. Sixteen clones were isolated, each containing unrearranged c-myc sequences and expressing high levels of antisense transcripts. All antisense clones examined contained reduced amounts of cytoplasmic endogenous c-myc transcripts. The kinetics of reaccumulation of endogenous c-myc mRNA during a 24-h exposure to dimethyl sulfoxide (DMSO) were also retarded and the ultimate transcript levels attained were less than in control cells. Antisense clones grew as well as control F-MEL cells in medium containing 10% fetal calf serum but at only a half and a quarter of the control rates in media containing 5 and 2% serum, respectively. Antisense clones differentiated faster and to a greater degree than control cells following DMSO exposure. myc antisense transcript expression was increased by growing cells in methotrexate, which resulted in an enhanced response to DMSO. Fluorescence-activated cell sorter (FACS) analysis of cellular DNA content indicated that a greater fraction of antisense nuclei contained a G0/G1 2n DNA content following a 24-h exposure to DMSO. When density-arrested antisense clones were diluted into fresh medium to allow reentry into the cell cycle, they incorporated less [3H]thymidine than control cells. FACS analysis showed that this was because only a portion of the cell population was entering S phase. Whereas control cells did not increase in size following release from density arrested antisense cells contained a subpopulation which were initially smaller and which eventually attained the same size as control cells. Quiescent antisense cells thus comprise two populations, each arrested at a different point in G1. Dilutional replating allowed both populations to reenter the cell cycle. We propose a model which postulates that certain minimal myc levels are necessary for cells to traverse G1. Those with insufficient levels, due, for example, to antisense inhibition, are unable to completely traverse G1 during density arrest and synchronize at an earlier point than do control cells. This earlier point may be along the differentiation pathway and may account for the greater responsiveness of antisense cells to DMSO induction. This model postulates that F-MEL cells overexpressing myc fail to differentiate because myc levels are never sufficiently low enough to allow cells to enter the differentiation pathway.
Similar articles
-
Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.Mol Cell Biol. 1988 Apr;8(4):1614-24. doi: 10.1128/mcb.8.4.1614-1624.1988. Mol Cell Biol. 1988. PMID: 2454393 Free PMC article.
-
Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation.Mol Cell Biol. 1988 Feb;8(2):884-92. doi: 10.1128/mcb.8.2.884-892.1988. Mol Cell Biol. 1988. PMID: 2832742 Free PMC article.
-
Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.Exp Cell Res. 1988 Oct;178(2):185-98. doi: 10.1016/0014-4827(88)90390-4. Exp Cell Res. 1988. PMID: 2458948
-
c-myc protooncogene expression in mouse erythroleukemia cells.Environ Health Perspect. 1989 Mar;80:161-72. doi: 10.1289/ehp.8980161. Environ Health Perspect. 1989. PMID: 2647476 Free PMC article. Review.
-
Induced differentiation of murine erythroleukemia cells: cellular and molecular mechanisms.Adv Cancer Res. 1984;42:149-66. doi: 10.1016/s0065-230x(08)60457-1. Adv Cancer Res. 1984. PMID: 6395654 Review.
Cited by
-
Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.Mol Cell Biol. 1991 Oct;11(10):5032-43. doi: 10.1128/mcb.11.10.5032-5043.1991. Mol Cell Biol. 1991. PMID: 1922031 Free PMC article.
-
c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle.Oncogene. 2008 Mar 20;27(13):1905-15. doi: 10.1038/sj.onc.1210823. Epub 2007 Oct 1. Oncogene. 2008. PMID: 17906696 Free PMC article.
-
Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma.J Clin Invest. 1991 Jun;87(6):1883-8. doi: 10.1172/JCI115212. J Clin Invest. 1991. PMID: 2040684 Free PMC article.
-
Kinetic resolution of bimolecular hybridization versus intramolecular folding in nucleic acids by surface plasmon resonance: application to G-quadruplex/duplex competition in human c-myc promoter.Nucleic Acids Res. 2005 Aug 5;33(14):4466-74. doi: 10.1093/nar/gki750. Print 2005. Nucleic Acids Res. 2005. PMID: 16085756 Free PMC article.
-
Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5176-80. doi: 10.1073/pnas.89.11.5176. Proc Natl Acad Sci U S A. 1992. PMID: 1594628 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources